

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.63999542 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.37248850 |
| 3 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.33095233 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.25461974 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.25461974 |
| 6 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.56914356 |
| 7 | * NIK/NF-kappaB signaling (GO:0038061) | 4.53983657 |
| 8 | response to muramyl dipeptide (GO:0032495) | 4.15718913 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.15196179 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.13802508 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.10165885 |
| 12 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.07755785 |
| 13 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.95639670 |
| 14 | myeloid dendritic cell differentiation (GO:0043011) | 3.89684338 |
| 15 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.84314477 |
| 16 | positive thymic T cell selection (GO:0045059) | 3.81633679 |
| 17 | negative thymic T cell selection (GO:0045060) | 3.77772915 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77765872 |
| 19 | T-helper 1 type immune response (GO:0042088) | 3.75267245 |
| 20 | negative T cell selection (GO:0043383) | 3.62106531 |
| 21 | regulation of vitamin metabolic process (GO:0030656) | 3.61012507 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59566767 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59566767 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.59566767 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59566767 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.59566767 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59566767 |
| 28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.55499138 |
| 29 | response to type I interferon (GO:0034340) | 3.54651156 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.52413154 |
| 31 | positive regulation of humoral immune response (GO:0002922) | 3.51346938 |
| 32 | myeloid dendritic cell activation (GO:0001773) | 3.51313099 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.51031655 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.51031655 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.50828406 |
| 36 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.46580115 |
| 37 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.45354055 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.42183764 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.41901499 |
| 40 | positive regulation of interleukin-12 production (GO:0032735) | 3.37686593 |
| 41 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.36975346 |
| 42 | tolerance induction (GO:0002507) | 3.36193242 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.31491609 |
| 44 | regulation of podosome assembly (GO:0071801) | 3.30614584 |
| 45 | detection of other organism (GO:0098543) | 3.27417353 |
| 46 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.25224968 |
| 47 | positive regulation of interleukin-2 production (GO:0032743) | 3.23687870 |
| 48 | thymic T cell selection (GO:0045061) | 3.23297443 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.23253875 |
| 50 | detection of bacterium (GO:0016045) | 3.21545910 |
| 51 | T cell migration (GO:0072678) | 3.19592565 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.19489590 |
| 53 | regulation of interleukin-12 production (GO:0032655) | 3.19296674 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.17913876 |
| 55 | leukocyte aggregation (GO:0070486) | 3.15390834 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.13979151 |
| 57 | response to interleukin-15 (GO:0070672) | 3.12088461 |
| 58 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.11296318 |
| 59 | regulation of antigen processing and presentation (GO:0002577) | 3.11120698 |
| 60 | growth hormone receptor signaling pathway (GO:0060396) | 3.11104492 |
| 61 | dendritic cell differentiation (GO:0097028) | 3.11077039 |
| 62 | positive regulation of type 2 immune response (GO:0002830) | 3.07558446 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.07363784 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03754461 |
| 65 | modulation by symbiont of host cellular process (GO:0044068) | 3.01908212 |
| 66 | defense response to protozoan (GO:0042832) | 3.01140132 |
| 67 | response to peptidoglycan (GO:0032494) | 3.01075121 |
| 68 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99111854 |
| 69 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.97904401 |
| 70 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.97765207 |
| 71 | activation of MAPKKK activity (GO:0000185) | 2.97533548 |
| 72 | T cell selection (GO:0045058) | 2.97366949 |
| 73 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.95754910 |
| 74 | natural killer cell mediated immunity (GO:0002228) | 2.95754910 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95107744 |
| 76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93808943 |
| 77 | regulation of response to interferon-gamma (GO:0060330) | 2.93577915 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.92495930 |
| 79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92249358 |
| 80 | negative regulation of cell killing (GO:0031342) | 2.92198181 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.92198181 |
| 82 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91648945 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.89513591 |
| 84 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.89440907 |
| 85 | positive regulation of heat generation (GO:0031652) | 2.89156080 |
| 86 | positive regulation of isotype switching (GO:0045830) | 2.87856915 |
| 87 | * germinal center formation (GO:0002467) | 2.87756403 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87288568 |
| 89 | mature B cell differentiation (GO:0002335) | 2.87095238 |
| 90 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.86127800 |
| 91 | response to protozoan (GO:0001562) | 2.83571618 |
| 92 | granulocyte activation (GO:0036230) | 2.82396748 |
| 93 | hepatocyte apoptotic process (GO:0097284) | 2.82279422 |
| 94 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.80434044 |
| 95 | neutrophil activation (GO:0042119) | 2.80225397 |
| 96 | positive T cell selection (GO:0043368) | 2.79654083 |
| 97 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.79024824 |
| 98 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.78556016 |
| 99 | positive regulation of B cell mediated immunity (GO:0002714) | 2.78556016 |
| 100 | detection of external biotic stimulus (GO:0098581) | 2.78147823 |
| 101 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.77393311 |
| 102 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.77333169 |
| 103 | B cell mediated immunity (GO:0019724) | 2.77265124 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77057499 |
| 105 | regulation of B cell differentiation (GO:0045577) | 2.76460891 |
| 106 | regulation of RIG-I signaling pathway (GO:0039535) | 2.76141772 |
| 107 | detection of molecule of bacterial origin (GO:0032490) | 2.75697880 |
| 108 | negative regulation of T cell mediated immunity (GO:0002710) | 2.74549210 |
| 109 | regulation of chronic inflammatory response (GO:0002676) | 2.73496885 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73335091 |
| 111 | regulation of T cell tolerance induction (GO:0002664) | 2.73332946 |
| 112 | natural killer cell differentiation (GO:0001779) | 2.72750620 |
| 113 | macrophage activation involved in immune response (GO:0002281) | 2.72687403 |
| 114 | cellular response to interferon-gamma (GO:0071346) | 2.72341368 |
| 115 | positive regulation of interleukin-17 production (GO:0032740) | 2.71734689 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.71646124 |
| 117 | regulation of necroptotic process (GO:0060544) | 2.70582379 |
| 118 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.70531147 |
| 119 | regulation of immunoglobulin secretion (GO:0051023) | 2.70184878 |
| 120 | regulation of fever generation (GO:0031620) | 2.69761302 |
| 121 | regulation of T-helper cell differentiation (GO:0045622) | 2.69571854 |
| 122 | response to host immune response (GO:0052572) | 2.69183924 |
| 123 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69183924 |
| 124 | cellular response to lipopolysaccharide (GO:0071222) | 2.68471102 |
| 125 | regulation of type 2 immune response (GO:0002828) | 2.67396940 |
| 126 | response to interferon-gamma (GO:0034341) | 2.66765363 |
| 127 | cellular response to zinc ion (GO:0071294) | 2.65430947 |
| 128 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.65291048 |
| 129 | regulation of natural killer cell differentiation (GO:0032823) | 2.65151788 |
| 130 | cytokine secretion (GO:0050663) | 2.64716245 |
| 131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.63933149 |
| 132 | cellular response to interleukin-15 (GO:0071350) | 2.63812766 |
| 133 | respiratory burst (GO:0045730) | 2.63783000 |
| 134 | cellular response to molecule of bacterial origin (GO:0071219) | 2.63516043 |
| 135 | positive regulation of interferon-beta production (GO:0032728) | 2.63455539 |
| 136 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.62429703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.26509516 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.88025224 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.16575954 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.14567879 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99761611 |
| 6 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.76707199 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61234328 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.48019239 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.07939798 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92048120 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.91270231 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.86898553 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.84597300 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81722981 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.77576436 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71732581 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69873690 |
| 18 | * MYC_22102868_ChIP-Seq_BL_Human | 2.68651083 |
| 19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.68574434 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56796366 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44066463 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39297286 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.34968821 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.22184611 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13676779 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13521699 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.00606210 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99588657 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97157719 |
| 30 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96346721 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95270532 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81639917 |
| 33 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79761068 |
| 34 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.78436262 |
| 35 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75786497 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70465276 |
| 37 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68796372 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.68735491 |
| 39 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.68368264 |
| 40 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66815618 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.66711990 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64321443 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61831397 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59235006 |
| 45 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.57798256 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51950057 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.49921689 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49020314 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46714268 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41976816 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41345039 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36800705 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35734514 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32997448 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32078420 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30938788 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22849852 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22408853 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21345456 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15350092 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14427714 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13587791 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13403074 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13400322 |
| 65 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12951022 |
| 66 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12836179 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12791314 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11058409 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10864309 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10721094 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10715300 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10653168 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07279152 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06224432 |
| 75 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05865158 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05372719 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05019077 |
| 78 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.03893366 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03482440 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03482440 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03107083 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02312059 |
| 83 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02036129 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01927445 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00853955 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98844649 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98521974 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96690831 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96509130 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96307377 |
| 91 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95787218 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95764882 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94892387 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94073358 |
| 95 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93491044 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92666070 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92165601 |
| 98 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92053739 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91665785 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91588470 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90109395 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89580595 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89417509 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88994222 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88293877 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86978321 |
| 107 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86255435 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85625986 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85051481 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84667125 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83745023 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82911910 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82425628 |
| 114 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81659981 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81314817 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79287504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.02237063 |
| 2 | MP0000685_abnormal_immune_system | 3.79894391 |
| 3 | MP0003303_peritoneal_inflammation | 3.42549994 |
| 4 | MP0001790_abnormal_immune_system | 3.30305366 |
| 5 | MP0005387_immune_system_phenotype | 3.30305366 |
| 6 | MP0003436_decreased_susceptibility_to | 3.29583079 |
| 7 | MP0004510_myositis | 3.23800926 |
| 8 | MP0009785_altered_susceptibility_to | 2.97089500 |
| 9 | * MP0001800_abnormal_humoral_immune | 2.88961398 |
| 10 | * MP0005000_abnormal_immune_tolerance | 2.84162634 |
| 11 | MP0005671_abnormal_response_to | 2.77907569 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.57277230 |
| 13 | MP0002254_reproductive_system_inflammat | 2.53354277 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.48212874 |
| 15 | * MP0002723_abnormal_immune_serum | 2.45431662 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.44389157 |
| 17 | MP0005451_abnormal_body_composition | 2.41682932 |
| 18 | * MP0005025_abnormal_response_to | 2.38838931 |
| 19 | MP0002419_abnormal_innate_immunity | 2.27007956 |
| 20 | * MP0001819_abnormal_immune_cell | 2.22871373 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.22469712 |
| 22 | MP0004947_skin_inflammation | 2.19144892 |
| 23 | MP0006082_CNS_inflammation | 2.12707134 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.07191334 |
| 25 | * MP0002405_respiratory_system_inflammati | 2.03034905 |
| 26 | * MP0003763_abnormal_thymus_physiology | 2.00935540 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.99580642 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.99101803 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.95995405 |
| 30 | MP0001853_heart_inflammation | 1.95248418 |
| 31 | * MP0002398_abnormal_bone_marrow | 1.93184212 |
| 32 | MP0001873_stomach_inflammation | 1.89819898 |
| 33 | MP0002006_tumorigenesis | 1.87893350 |
| 34 | MP0003724_increased_susceptibility_to | 1.86798955 |
| 35 | MP0009278_abnormal_bone_marrow | 1.84134168 |
| 36 | * MP0000716_abnormal_immune_system | 1.82017514 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.69724058 |
| 38 | * MP0001845_abnormal_inflammatory_respons | 1.67703786 |
| 39 | MP0005310_abnormal_salivary_gland | 1.67115302 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.66516585 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.65234173 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.55878704 |
| 43 | * MP0000689_abnormal_spleen_morphology | 1.54602509 |
| 44 | MP0003448_altered_tumor_morphology | 1.52802578 |
| 45 | * MP0002722_abnormal_immune_system | 1.50749127 |
| 46 | * MP0002429_abnormal_blood_cell | 1.49770741 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.42124819 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.41513485 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.41513485 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.39798883 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.36700321 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.35520787 |
| 53 | MP0002933_joint_inflammation | 1.35308898 |
| 54 | * MP0009333_abnormal_splenocyte_physiolog | 1.35133293 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.32913603 |
| 56 | MP0008260_abnormal_autophagy | 1.31302770 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.30918149 |
| 58 | MP0000858_altered_metastatic_potential | 1.30404907 |
| 59 | * MP0000703_abnormal_thymus_morphology | 1.28797020 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.28221022 |
| 61 | MP0008004_abnormal_stomach_pH | 1.27560511 |
| 62 | MP0003866_abnormal_defecation | 1.25624052 |
| 63 | MP0008469_abnormal_protein_level | 1.24502377 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.15445771 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.14467820 |
| 66 | * MP0003091_abnormal_cell_migration | 1.11357838 |
| 67 | MP0005023_abnormal_wound_healing | 1.11104544 |
| 68 | MP0009764_decreased_sensitivity_to | 1.10509640 |
| 69 | MP0010307_abnormal_tumor_latency | 1.09322038 |
| 70 | MP0009840_abnormal_foam_cell | 1.08961074 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.03126456 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.98742549 |
| 73 | MP0000343_altered_response_to | 0.97857772 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.96014624 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.94825440 |
| 76 | MP0003045_fibrosis | 0.90969666 |
| 77 | MP0001851_eye_inflammation | 0.90843974 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.90678259 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.89350341 |
| 80 | MP0000604_amyloidosis | 0.84148189 |
| 81 | MP0000733_abnormal_muscle_development | 0.83868532 |
| 82 | MP0005390_skeleton_phenotype | 0.83753569 |
| 83 | MP0000490_abnormal_crypts_of | 0.81693401 |
| 84 | MP0005164_abnormal_response_to | 0.80783210 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.78918902 |
| 86 | MP0003828_pulmonary_edema | 0.78159373 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.77790652 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.74955906 |
| 89 | MP0003690_abnormal_glial_cell | 0.74435606 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.74280501 |
| 91 | MP0001849_ear_inflammation | 0.73826365 |
| 92 | MP0001881_abnormal_mammary_gland | 0.73063405 |
| 93 | MP0000249_abnormal_blood_vessel | 0.72550892 |
| 94 | * MP0009763_increased_sensitivity_to | 0.72546600 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.72152499 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.71849918 |
| 97 | MP0003075_altered_response_to | 0.71718155 |
| 98 | MP0008874_decreased_physiological_sensi | 0.71100979 |
| 99 | MP0008057_abnormal_DNA_replication | 0.69308344 |
| 100 | MP0001958_emphysema | 0.66531179 |
| 101 | MP0006054_spinal_hemorrhage | 0.66464994 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.65921142 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65510512 |
| 104 | MP0008438_abnormal_cutaneous_collagen | 0.65341745 |
| 105 | MP0001216_abnormal_epidermal_layer | 0.63604366 |
| 106 | MP0001243_abnormal_dermal_layer | 0.62027736 |
| 107 | * MP0003795_abnormal_bone_structure | 0.61834881 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.61327488 |
| 109 | * MP0002136_abnormal_kidney_physiology | 0.59863467 |
| 110 | MP0004883_abnormal_blood_vessel | 0.59157674 |
| 111 | * MP0000609_abnormal_liver_physiology | 0.58844933 |
| 112 | MP0003279_aneurysm | 0.58173018 |
| 113 | MP0001663_abnormal_digestive_system | 0.57845395 |
| 114 | MP0005165_increased_susceptibility_to | 0.57800188 |
| 115 | MP0005166_decreased_susceptibility_to | 0.57778342 |
| 116 | MP0001346_abnormal_lacrimal_gland | 0.56685065 |
| 117 | MP0000371_diluted_coat_color | 0.56126275 |
| 118 | MP0001191_abnormal_skin_condition | 0.56083953 |
| 119 | MP0000627_abnormal_mammary_gland | 0.55563809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.50680660 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.97596286 |
| 3 | Recurrent fungal infections (HP:0002841) | 4.45974732 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.40584720 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.40584720 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.40584720 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.38086805 |
| 8 | Stomatitis (HP:0010280) | 4.32159720 |
| 9 | Myositis (HP:0100614) | 4.13706623 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.04161587 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.98824687 |
| 12 | Recurrent viral infections (HP:0004429) | 3.92649905 |
| 13 | Orchitis (HP:0100796) | 3.92410757 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.82823162 |
| 15 | Optic neuritis (HP:0100653) | 3.82823162 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.81387780 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.81387780 |
| 18 | Chronic otitis media (HP:0000389) | 3.63685490 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.41543414 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.40297728 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.40245959 |
| 22 | Nasal polyposis (HP:0100582) | 3.39971707 |
| 23 | Loss of speech (HP:0002371) | 3.37451647 |
| 24 | Recurrent skin infections (HP:0001581) | 3.32155580 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.27596069 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.24071287 |
| 27 | * Vasculitis (HP:0002633) | 3.23643243 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.22803046 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.20732067 |
| 30 | Cellulitis (HP:0100658) | 3.20637720 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.18424749 |
| 32 | Colitis (HP:0002583) | 3.13267493 |
| 33 | Increased density of long bones (HP:0006392) | 3.10472228 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 3.07200702 |
| 35 | Arterial thrombosis (HP:0004420) | 3.05321330 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.05043615 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03496354 |
| 38 | Increased IgE level (HP:0003212) | 3.00974290 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.99256756 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.99073538 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.98965761 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.97649714 |
| 43 | Pustule (HP:0200039) | 2.89359725 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.87842463 |
| 45 | Increased IgM level (HP:0003496) | 2.86007174 |
| 46 | Persistence of primary teeth (HP:0006335) | 2.85678411 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.83439103 |
| 48 | Gingivitis (HP:0000230) | 2.82696522 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.79114384 |
| 50 | Myocardial infarction (HP:0001658) | 2.77643918 |
| 51 | T lymphocytopenia (HP:0005403) | 2.77325451 |
| 52 | Peritonitis (HP:0002586) | 2.76937905 |
| 53 | Thrombocytosis (HP:0001894) | 2.72940150 |
| 54 | Hematochezia (HP:0002573) | 2.71554041 |
| 55 | Meningitis (HP:0001287) | 2.71107144 |
| 56 | Leukocytosis (HP:0001974) | 2.67469371 |
| 57 | Abnormality of T cells (HP:0002843) | 2.65260857 |
| 58 | Periodontitis (HP:0000704) | 2.63798307 |
| 59 | IgA deficiency (HP:0002720) | 2.59914529 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59689689 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.56735804 |
| 62 | Osteomyelitis (HP:0002754) | 2.54566379 |
| 63 | Increased serum ferritin (HP:0003281) | 2.52664157 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.51154515 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.47912379 |
| 66 | Autoimmune hemolytic anemia (HP:0001890) | 2.47492150 |
| 67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45716589 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.45716589 |
| 69 | Disinhibition (HP:0000734) | 2.45664493 |
| 70 | Gangrene (HP:0100758) | 2.44794844 |
| 71 | Hemoptysis (HP:0002105) | 2.44134943 |
| 72 | * Emphysema (HP:0002097) | 2.40208803 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40145067 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40145067 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40145067 |
| 76 | Obstructive lung disease (HP:0006536) | 2.39990574 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39990574 |
| 78 | IgM deficiency (HP:0002850) | 2.38033858 |
| 79 | Nuclear cataract (HP:0100018) | 2.33973315 |
| 80 | Fatigue (HP:0012378) | 2.29977943 |
| 81 | Eosinophilia (HP:0001880) | 2.29820270 |
| 82 | Vertebral compression fractures (HP:0002953) | 2.29783304 |
| 83 | Abnormality of the fingertips (HP:0001211) | 2.28763881 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27693821 |
| 85 | Mucopolysacchariduria (HP:0008155) | 2.27693821 |
| 86 | Malnutrition (HP:0004395) | 2.23054307 |
| 87 | Urticaria (HP:0001025) | 2.22487026 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21203739 |
| 89 | Spontaneous hematomas (HP:0007420) | 2.19451969 |
| 90 | Chronic diarrhea (HP:0002028) | 2.18936512 |
| 91 | Chest pain (HP:0100749) | 2.17793855 |
| 92 | Skin ulcer (HP:0200042) | 2.14678253 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.14009089 |
| 94 | Gingival bleeding (HP:0000225) | 2.13816858 |
| 95 | Abnormality of the pleura (HP:0002103) | 2.10123857 |
| 96 | Thin bony cortex (HP:0002753) | 2.09758581 |
| 97 | Tetraparesis (HP:0002273) | 2.08658436 |
| 98 | Purpura (HP:0000979) | 2.07440482 |
| 99 | Verrucae (HP:0200043) | 2.07045667 |
| 100 | Papilloma (HP:0012740) | 2.07045667 |
| 101 | Glomerulonephritis (HP:0000099) | 2.06173082 |
| 102 | Joint swelling (HP:0001386) | 2.05276863 |
| 103 | * Restrictive lung disease (HP:0002091) | 2.04738160 |
| 104 | Thick nail (HP:0001805) | 2.04646899 |
| 105 | Chronic sinusitis (HP:0011109) | 2.04516274 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 2.04473476 |
| 107 | * Gastrointestinal stroma tumor (HP:0100723) | 2.02675647 |
| 108 | IgG deficiency (HP:0004315) | 2.02647361 |
| 109 | Axonal loss (HP:0003447) | 2.01511319 |
| 110 | Frequent falls (HP:0002359) | 2.01465559 |
| 111 | Neurofibrillary tangles (HP:0002185) | 2.00776933 |
| 112 | Basal ganglia calcification (HP:0002135) | 2.00630882 |
| 113 | Abnormality of eosinophils (HP:0001879) | 1.99530377 |
| 114 | Amyloidosis (HP:0011034) | 1.99502745 |
| 115 | Recurrent sinusitis (HP:0011108) | 1.97907788 |
| 116 | Anorexia (HP:0002039) | 1.97663550 |
| 117 | Hypertensive crisis (HP:0100735) | 1.96105324 |
| 118 | Petechiae (HP:0000967) | 1.95684848 |
| 119 | Esophageal varix (HP:0002040) | 1.94503626 |
| 120 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94348757 |
| 121 | Granulocytopenia (HP:0001913) | 1.93576939 |
| 122 | Polyneuropathy (HP:0001271) | 1.93460916 |
| 123 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92042273 |
| 124 | Hepatosplenomegaly (HP:0001433) | 1.91239288 |
| 125 | Glomerulopathy (HP:0100820) | 1.91047363 |
| 126 | Pulmonary embolism (HP:0002204) | 1.90872326 |
| 127 | Porencephaly (HP:0002132) | 1.90776133 |
| 128 | Increased cerebral lipofuscin (HP:0011813) | 1.88469668 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.88048994 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.87364846 |
| 131 | Encephalitis (HP:0002383) | 1.85838642 |
| 132 | * Arthralgia (HP:0002829) | 1.85769057 |
| 133 | Prostate neoplasm (HP:0100787) | 1.85266733 |
| 134 | Abnormality of the pericardium (HP:0001697) | 1.84567958 |
| 135 | Severe combined immunodeficiency (HP:0004430) | 1.84254709 |
| 136 | Combined immunodeficiency (HP:0005387) | 1.83113424 |
| 137 | * Lymphopenia (HP:0001888) | 1.82907748 |
| 138 | Abnormality of the peritoneum (HP:0002585) | 1.81889262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.09275261 |
| 2 | PRPF4B | 3.48479382 |
| 3 | JAK3 | 3.25324853 |
| 4 | TBK1 | 3.20813963 |
| 5 | TYK2 | 3.12503372 |
| 6 | * MAP3K14 | 2.90212838 |
| 7 | IKBKB | 2.65859466 |
| 8 | IKBKE | 2.64051381 |
| 9 | MAP3K10 | 2.45868873 |
| 10 | IRAK3 | 2.38567477 |
| 11 | TXK | 2.26637494 |
| 12 | EPHB1 | 2.21812335 |
| 13 | JAK1 | 2.20952956 |
| 14 | MAP3K13 | 2.13263195 |
| 15 | ERN1 | 2.12421666 |
| 16 | FGFR4 | 2.07776732 |
| 17 | SMG1 | 1.92593490 |
| 18 | ZAP70 | 1.92592913 |
| 19 | IRAK4 | 1.90270312 |
| 20 | TRIB3 | 1.90007914 |
| 21 | * CHUK | 1.81961190 |
| 22 | RPS6KA4 | 1.77384433 |
| 23 | BLK | 1.75610218 |
| 24 | RIPK4 | 1.72214061 |
| 25 | DDR2 | 1.71714468 |
| 26 | KIT | 1.71197556 |
| 27 | EPHA3 | 1.69139516 |
| 28 | STK10 | 1.65916542 |
| 29 | EEF2K | 1.56841995 |
| 30 | CDK12 | 1.52377118 |
| 31 | CDC42BPA | 1.48287617 |
| 32 | PIM2 | 1.46954547 |
| 33 | CSK | 1.41169578 |
| 34 | TTN | 1.40598173 |
| 35 | FGFR3 | 1.39386487 |
| 36 | BTK | 1.34880049 |
| 37 | PTK6 | 1.33721738 |
| 38 | LRRK2 | 1.32620882 |
| 39 | GRK7 | 1.30679827 |
| 40 | HCK | 1.28775193 |
| 41 | ITK | 1.27237101 |
| 42 | PIM1 | 1.26312307 |
| 43 | SYK | 1.23919373 |
| 44 | MAP2K3 | 1.22720369 |
| 45 | CSF1R | 1.20675646 |
| 46 | LCK | 1.15968521 |
| 47 | IRAK2 | 1.14647305 |
| 48 | GRK6 | 1.13398774 |
| 49 | PKN2 | 1.12375051 |
| 50 | NLK | 1.09695719 |
| 51 | BMPR2 | 1.09313291 |
| 52 | ICK | 1.04211771 |
| 53 | JAK2 | 1.01557349 |
| 54 | BMX | 0.99203988 |
| 55 | SIK1 | 0.98876405 |
| 56 | TEC | 0.97651889 |
| 57 | MAP3K3 | 0.97502851 |
| 58 | PIK3CG | 0.92383548 |
| 59 | MARK3 | 0.91762052 |
| 60 | SIK2 | 0.89303971 |
| 61 | TGFBR2 | 0.89135444 |
| 62 | MAP3K11 | 0.84514123 |
| 63 | SIK3 | 0.83694773 |
| 64 | MST4 | 0.82154834 |
| 65 | NME2 | 0.80626471 |
| 66 | RIPK1 | 0.75570131 |
| 67 | ALK | 0.75562016 |
| 68 | FLT3 | 0.73958662 |
| 69 | TNK2 | 0.73331044 |
| 70 | LYN | 0.69609034 |
| 71 | TAOK3 | 0.68280499 |
| 72 | TESK2 | 0.66237937 |
| 73 | TYRO3 | 0.63470496 |
| 74 | TAOK1 | 0.62575506 |
| 75 | MAP3K7 | 0.61861816 |
| 76 | MARK2 | 0.61597229 |
| 77 | MAPKAPK2 | 0.59436677 |
| 78 | NEK9 | 0.58356652 |
| 79 | IRAK1 | 0.57932951 |
| 80 | PDGFRA | 0.56595536 |
| 81 | CLK1 | 0.55843292 |
| 82 | MAP3K8 | 0.55619482 |
| 83 | PDGFRB | 0.54302599 |
| 84 | EGFR | 0.53204739 |
| 85 | PRKD2 | 0.52300288 |
| 86 | MAPK7 | 0.52125987 |
| 87 | RPS6KA5 | 0.51555228 |
| 88 | ARAF | 0.50800319 |
| 89 | MATK | 0.50167689 |
| 90 | PDK1 | 0.49782693 |
| 91 | TGFBR1 | 0.49377840 |
| 92 | PDPK1 | 0.48920658 |
| 93 | ABL1 | 0.48460164 |
| 94 | RPS6KL1 | 0.48350600 |
| 95 | RPS6KC1 | 0.48350600 |
| 96 | PRKCQ | 0.47372749 |
| 97 | CDK4 | 0.47272634 |
| 98 | MAPK11 | 0.46520270 |
| 99 | FGR | 0.45327244 |
| 100 | MAP3K1 | 0.44923527 |
| 101 | RPS6KA1 | 0.44567903 |
| 102 | KSR2 | 0.44308167 |
| 103 | TRPM7 | 0.44292858 |
| 104 | KDR | 0.42054854 |
| 105 | CDK6 | 0.40916982 |
| 106 | MAPK4 | 0.40847656 |
| 107 | STK4 | 0.39940953 |
| 108 | MAP3K5 | 0.38603620 |
| 109 | PAK4 | 0.37831891 |
| 110 | INSR | 0.37786118 |
| 111 | MELK | 0.36986390 |
| 112 | STK3 | 0.36311373 |
| 113 | MTOR | 0.36004662 |
| 114 | MAP2K6 | 0.33419754 |
| 115 | HIPK2 | 0.32305750 |
| 116 | RPS6KA6 | 0.30587059 |
| 117 | FES | 0.30459557 |
| 118 | RPS6KA2 | 0.30182126 |
| 119 | GSK3A | 0.29207066 |
| 120 | MAPK12 | 0.28862221 |
| 121 | TAOK2 | 0.28562251 |
| 122 | TSSK6 | 0.26587084 |
| 123 | MOS | 0.26323815 |
| 124 | PRKCH | 0.25857439 |
| 125 | CDK9 | 0.25622397 |
| 126 | DMPK | 0.24708727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.05136361 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94706347 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.55512463 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53351352 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49018902 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.42863131 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41253348 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.35349471 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31301010 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20787390 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.20722005 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.20209190 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20191848 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05006888 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.01931846 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98244245 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.88001579 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78493480 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.77156925 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.76909297 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.73553269 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69563213 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66533965 |
| 24 | * Legionellosis_Homo sapiens_hsa05134 | 1.66321194 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.63926683 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57845559 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57309684 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.55093393 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.54352119 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46529666 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46050054 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43981010 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42682475 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.41507523 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39908329 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.39736433 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39296422 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37109076 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34449060 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34431299 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34399142 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33541201 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26235269 |
| 44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.22642378 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17938996 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.17275168 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14576023 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14442799 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.12927595 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10049599 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07817568 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.04775203 |
| 53 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99588282 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95245475 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93130348 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.91578630 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91326883 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.90776052 |
| 59 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90330849 |
| 60 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.90296665 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78131717 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75585283 |
| 63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73889407 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70818317 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.69106865 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65881161 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.65431616 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64524612 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61853384 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57771324 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55413419 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54443324 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53543179 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.52281485 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.50889418 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.50599297 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49046621 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48005867 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47967685 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47751525 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47614553 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47445564 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46793234 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.46126791 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45058287 |
| 86 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43601819 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42831640 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42559417 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.37709345 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36887449 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36718244 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36496701 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33737750 |
| 94 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.32486846 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32067017 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31815442 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.31456528 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29924822 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29915736 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29416584 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27923840 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.26588773 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26397643 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26142688 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25088458 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25020753 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.24853640 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24754568 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24635082 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.22431406 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22406053 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22174536 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21893981 |

